Show simple item record

Efecto del manejo con concentrado de protrombina en comparación al plasma fresco congelado, en la hemorragia Intracerebral asociada a warfarina: Ensayo Clínico Aleatorizado; Estudio scorpio

dc.contributor.advisorCarreño Rodríguez, José Nel
dc.contributor.advisorGiraldo Cadavid, Luis Fernando
dc.contributor.authorSalazar Triviño, Carlos Hernando
dc.date.accessioned2013-12-16T17:45:32Z
dc.date.available2013-12-16T17:45:32Z
dc.date.created2013-12-16
dc.date.issued2012
dc.identifier.citationAdeoye, O., Woo, D., Haverbusch, M., Tao, H., Sekar, P., Moomaw, C. J., Flaherty, M. L. (2008). Eligibility for the surgical trial in intracerebral hemorrhage II study in a population-based cohort. Neurocritical Care, 9(2), 237-41. doi:10.1007/s12028-007-9045-8.
dc.identifier.citation.Aguilar, M. I., Hart, R. G., Kase, C. S., Freeman, W. D., Hoeben, B. J., García, R. C., Yasaka, M. (2007). Treatment of warfarin-associated intracerebral hemorrhage: Literature review and expert opinion. Mayo Clinic Proceedings. Mayo Clinic, 82(1), 82-92.
dc.identifier.citationAiyagari, V. (2009). Correction of coagulopathy secondary to oral and parenteral anticoagulants. Continuum Lifelong Learning Neurol 2009;15(3).
dc.identifier.citationAiyagari, V., & Testai, F. D. (2009). Correction of coagulopathy in warfarin associated cerebral hemorrhage. Current Opinion in Critical Care, 15(2), 87-92. doi:10.1097/MCC.0b013e3283269e4d
dc.identifier.citationAnderson, C. S. (2009). Medical management of acute intracerebral hemorrhage. Current Opinion in Critical Care, 15(2), 93-8. doi:10.1097/MCC. 0b013e328325d12c.
dc.identifier.citationAnsell, J., Hirsh, J., Hylek, E., Jacobson, A., Crowther, M., Palareti, G., & American College of Chest Physicians. (2008). Pharmacology and management of the vitamin K antagonists: American college of chest physicians evidence-based clinical practice guidelines (8th edition). Chest, 133(6 Suppl), 160S-198S. doi:10.1378/chest.08-0670
dc.identifier.citationBaglin, T. P., Keeling, D. M., Watson, H. G., & British Committee for Standards in Haematology. (2006). Guidelines on oral anticoagulation (warfarin): Third edition--2005 update. British Journal of Haematology, 132(3), 277-85. doi:10.1111/j.1365-2141.2005.05856.x.
dc.identifier.citationBaker, R. I., Coughlin, P. B., Gallus, A. S., Harper, P. L., Salem, H. H., Wood, E. M., & Warfarin Reversal Consensus Group. (2004). Warfarin reversal: Consensus guidelines, on behalf of the australasian society of thrombosis and haemostasis. The Medical Journal of Australia, 181(9), 492-7
dc.identifier.citationBechtel, B. F., Nunez, T. C., Lyon, J. A., Cotton, B. A., & Barrett, T. W. (2011). Treatments for reversing warfarin anticoagulation in patients with acute intracranial hemorrhage: A structured literature review. International Journal of Emergency Medicine, 4(1), 40. doi:10.1186/1865-1380-4-40.
dc.identifier.citationBroderick, J., Connolly, S., Feldmann, E., Hanley, D., Kase, C., Krieger, D., Quality of Care and Outcomes in Research Interdisciplinary Working Group. (2007). Guidelines for the management of spontaneous intracerebral hemorrhage in adults: 2007 update: A guideline from the american heart association/american stroke association stroke council, high blood pressure research council, and the quality of care and outcomes in research interdisciplinary working group. Stroke; A Journal of Cerebral Circulation, 38(6), 2001-23. doi:10.1161/STROKEAHA.107.183689
dc.identifier.citationCartmill, M., Dolan, G., Byrne, J. L., & Byrne, P. O. (2000). Prothrombin complex concentrate for oral anticoagulant reversal in neurosurgical emergencies. British Journal of Neurosurgery, 14(5), 458-61.
dc.identifier.citationCohen, D. B., Rinker, C., & Wilberger, J. E. (2006). Traumatic brain injury in anticoagulated patients. The Journal of Trauma, 60(3), 553-7. doi: 10.1097/01.ta.0000196542.54344.05.
dc.identifier.citationDemeyere, R., Gillardin, S., Arnout, J., & Strengers, P. F. (2010). Comparison of fresh frozen plasma and prothrombin complex concentrate for the reversal of oral anticoagulants in patients undergoing cardiopulmonary bypass surgery: A randomized study. Vox Sanguinis, 99(3), 251-60. doi:10.1111/j.1423-0410.2010.01339.x.
dc.identifier.citationDouketis, J. D., Berger, P. B., Dunn, A. S., Jaffer, A. K., Spyropoulos, A. C., Becker, R. C., American College of Chest Physicians. (2008). The perioperative management of antithrombotic therapy: American college of chest physicians evidence-based clinical practice guidelines (8th edition). Chest, 133(6 Suppl), 299S-339S. doi:10.1378/chest.08-0675.
dc.identifier.citationDusel, C. H., Grundmann, C., Eich, S., Seitz, R., & König, H. (2004). Identification of prothrombin as a major thrombogenic agent in prothrombin complex concentrates. Blood Coagulation & Fibrinolysis : An International Journal in Haemostasis and Thrombosis, 15(5), 405-11.
dc.identifier.citationElliott, J., & Smith, M. (2010). The acute management of intracerebral hemorrhage: A clinical review. Anesthesia and Analgesia, 110(5), 1419-27. doi:10.1213/ANE.0b013e3181d568c8.
dc.identifier.citationFlaherty, M. L., Tao, H., Haverbusch, M., Sekar, P., Kleindorfer, D., Kissela, B., Woo, D. (2008). Warfarin use leads to larger intracerebral hematomas. Neurology, 71(14), 1084-9. doi:10.1212/01.wnl.0000326895.58992.27
dc.identifier.citationFoerch, C., Arai, K., Van Cott, E. M., van Leyen, K., & Lo, E. H. (2009). Rapid reversal of anticoagulation reduces hemorrhage volume in a mouse model of warfarin-associated intracerebral hemorrhage. Journal of Cerebral Blood Flow and Metabolism: Official Journal of the International Society of Cerebral Blood Flow and Metabolism, 29(5), 1015-21. doi:10.1038/jcbfm. 2009.27.
dc.identifier.citationFric-Shamji, E. C., Shamji, M. F., Cole, J., & Benoit, B. G. (2008). Modifiable risk factors for intracerebral hemorrhage. Canadian Family Physician, 54(8), 1138.
dc.identifier.citationGoldstein, J. N., Rosand, J., & Schwamm, L. H. (2008). Warfarin reversal in anticoagulant-associated intracerebral hemorrhage. Neurocritical Care, 9(2), 277-83. doi:10.1007/s12028-008-9049-z
dc.identifier.citationGrobler, C., Callum, J., & McCluskey, S. A. (2010). Reversal of vitamin K antagonists prior to urgent surgery. Canadian Journal of Anaesthesia, 57(5), 458-67. doi:10.1007/s12630-009-9250-3.
dc.identifier.citationHuttner, H. B., Schellinger, P. D., Hartmann, M., Köhrmann, M., Juettler, E., Wikner, J., Steiner, T. (2006). Hematoma growth and outcome in treated neurocritical care patients with intracerebral hemorrhage related to oral anticoagulant therapy: Comparison of acute treatment strategies using vitamin K, fresh frozen plasma, and prothrombin complex concentrates. Stroke; A Journal of Cerebral Circulation, 37(6), 1465-70. doi: 10.1161/01.STR.0000221786.81354.d6
dc.identifier.citationKirkman, M. A., Mahattanakul, W., Gregson, B. A., & Mendelow, A. D. (2008). The effect of the results of the STICH trial on the management of spontaneous supratentorial intracerebral haemorrhage in newcastle. British Journal of Neurosurgery, 22(6), 739-46; discussion 747. doi: 10.1080/02688690802346091.
dc.identifier.citationKraai, E. P., Lopes, R. D., Alexander, J. H., & Garcia, D. (2009). Perioperative management of anticoagulation: Guidelines translated for the clinician. Journal of Thrombosis and Thrombolysis, 28(1), 16-22. doi: 10.1007/s11239-009-0313-7
dc.identifier.citationLeissinger, C. A., Blatt, P. M., Hoots, W. K., & Ewenstein, B. (2008). Role of prothrombin complex concentrates in reversing warfarin anticoagulation: A review of the literature. American Journal of Hematology, 83(2), 137-43. doi:10.1002/ajh.21046.
dc.identifier.citationLevi, M. (2009). Epidemiology and management of bleeding in patients using vitamin K antagonists. Journal of Thrombosis and Haemostasis : JTH, 7 Suppl 1, 103-6. doi:10.1111/j.1538-7836.2009.03389.x.
dc.identifier.citationLevi, M., Levy, J. H., Andersen, H. F., & Truloff, D. (2010). Safety of recombinant activated factor VII in randomized clinical trials. New England Journal of Medicine, 363(19), 1791-1800.
dc.identifier.citationLevy, J. H., Tanaka, K. A., & Dietrich, W. (2008). Perioperative hemostatic management of patients treated with vitamin K antagonists. Anesthesiology, 109(5), 918-26. doi:10.1097/ALN.0b013e3181895bd8
dc.identifier.citationLiumbruno, G., Bennardello, F., Lattanzio, A., Piccoli, P., Rossetti, G., & Italian Society of Transfusion Medicine and Immunohaematology (SIMTI) Working Party. (2009). Recommendations for the use of antithrombin concentrates and prothrombin complex concentrates. Blood Transfusion, 7(4), 325-34. doi:10.2450/2009.0116-09.
dc.identifier.citationLubetsky, A., Hoffman, R., Zimlichman, R., Eldor, A., Zvi, J., Kostenko, V., & Brenner, B. (2004). Efficacy and safety of a prothrombin complex concentrate (octaplex) for rapid reversal of oral anticoagulation. Thrombosis Research, 113(6), 371-8. doi:10.1016/j.thromres.2004.04.004
dc.identifier.citationMaria, H., & Wexler, S. (2008). Guidelines for the management of warfarin reversal. Royal United Hospital Bath.
dc.identifier.citationMayer, S. A., Brun, N. C., Begtrup, K., Broderick, J., Davis, S., Diringer, M. N., FAST Trial Investigators. (2008). Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage. The New England Journal of Medicine, 358(20), 2127-37. doi:10.1056/NEJMoa0707534.
dc.identifier.citationMayer, S. A., Davis, S. M., Skolnick, B. E., Brun, N. C., Begtrup, K., Broderick, J. P., FAST trial investigators. (2009). Can a subset of intracerebral hemorrhage patients benefit from hemostatic therapy with recombinant activated factor VII? Stroke; A Journal of Cerebral Circulation, 40(3), 833-40. doi:10.1161/STROKEAHA.108.524470
dc.identifier.citationMendelow, A. D., Gregson, B. A., Fernandes, H. M., Murray, G. D., Teasdale, G. M., Hope, D. T., Barer, D. H. (2005). STICH investigators. Early surgery versus initial conservative treatment in patients with spontaneous supratentorial intracerebral haematomas in the international surgical trial in intracerebral haemorrhage (STICH): A randomised trial. Lancet, 365(9457), 387-97.
dc.identifier.citationMorgenstern, L. B., Hemphill, J. C., Anderson, C., Becker, K., Broderick, J. P., Connolly, E. S., American Heart Association Stroke Council and Council on Cardiovascular Nursing. (2010). Guidelines for the management of spontaneous intracerebral hemorrhage: A guideline for healthcare professionals from the american heart association/american stroke association. Stroke; A Journal of Cerebral Circulation, 41(9), 2108-29. doi: 10.1161/STR.0b013e3181ec611b.
dc.identifier.citationNarayan, R. K., Maas, A. I., Marshall, L. F., Servadei, F., Skolnick, B. E., Tillinger, M. N., & rFVIIa Traumatic ICH Study Group. (2008). Recombinant factor VIIA in traumatic intracerebral hemorrhage: Results of a dose-escalation clinical trial. Neurosurgery, 62(4), 776-86; discussion 786-8. doi:10.1227/01.neu.0000316898.78371.74.
dc.identifier.citationPieracci, F. M., Eachempati, S. R., Shou, J., Hydo, L. J., & Barie, P. S. (2007). Degree of anticoagulation, but not warfarin use itself, predicts adverse outcomes after traumatic brain injury in elderly trauma patients. The Journal of Trauma, 63(3), 525-30. doi:10.1097/TA.0b013e31812e5216
dc.identifier.citationRoback, J. D., Caldwell, S., Carson, J., Davenport, R., Drew, M. J., Eder, A., American Society of Hematology. (2010). Evidence-Based practice guidelines for plasma transfusion. Transfusion, 50(6), 1227-39. doi:10.1111/ j.1537-2995.2010.02632.x.
dc.identifier.citationRosovsky, R. P., & Crowther, M. A. (2008). What is the evidence for the offlabel use of recombinant factor viia (rfviia) in the acute reversal of warfarin? ASH evidence-based review 2008. Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program, 36-8. doi:10.1182/asheducation-2008.1.36.
dc.identifier.citationRønning, P., Sorteberg, W., Nakstad, P., Russell, D., & Helseth, E. (2008). Aspects of intracerebral hematomas; an update. Acta Neurologica Scandinavica, 118(6), 347-61. doi:10.1111/j.1600-0404.2008.01023.x.
dc.identifier.citationSchick, K. S., Fertmann, J. M., Jauch, K. W., & Hoffmann, J. N. (2009). Prothrombin complex concentrate in surgical patients: Retrospective evaluation of vitamin K antagonist reversal and treatment of severe bleeding. Critical Care (London, England), 13(6), R191. doi:10.1186/cc8186.
dc.identifier.citationSchulman, S., Beyth, R. J., Kearon, C., Levine, M. N., & American College of Chest Physicians. (2008). Hemorrhagic complications of anticoagulant and thrombolytic treatment: American college of chest physicians evidencebased clinical practice guidelines (8th edition). Chest, 133(6 Suppl), 257S-298S. doi:10.1378/chest.08-0674.
dc.identifier.citationSiddiq, F., Jalil, A., McDaniel, C., Brock, D. G., Pineda, C. C., Bell, R. D., & Lee, K. (2008). Effectiveness of factor IX complex concentrate in reversing warfarin associated coagulopathy for intracerebral hemorrhage. Neurocritical Care, 8(1), 36-41. doi:10.1007/s12028-007-9011-5.
dc.identifier.citationSjöblom, L., Hårdemark, H. G., Lindgren, A., Norrving, B., Fahlen, M., Samuelsson, M., Wallrup, L. (2001). Management and prognostic features of intracerebral hemorrhage during anticoagulant therapy. Stroke; A Journal of Cerebral Circulation, 32(11), 2567-2574. doi:10.1161/hs1101.098523.
dc.identifier.citationSpyropoulos, A. C., & Turpie, A. G. (2005). Perioperative bridging interruption with heparin for the patient receiving long-term anticoagulation. Current Opinion in Pulmonary Medicine, 11(5), 373-9
dc.identifier.citationStanworth, S. J. (2007). The evidence-based use of FFP and cryoprecipitate for abnormalities of coagulation tests and clinical coagulopathy. Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program, 179-86. doi:10.1182/asheducation-2007.1.179
dc.identifier.citationStanworth, S. J., Grant-Casey, J., Lowe, D., Laffan, M., New, H., Murphy, M. F., & Allard, S. (2011). The use of fresh-frozen plasma in england: High levels of inappropriate use in adults and children. Transfusion, 51(1), 62-70. doi:10.1111/j.1537-2995.2010.02798.x.
dc.identifier.citationSteiner, T., & Bösel, J. (2010). Options to restrict hematoma expansion after spontaneous intracerebral hemorrhage. Stroke; A Journal of Cerebral Circulation, 41(2), 402-9. doi:10.1161/STROKEAHA.109.552919.
dc.identifier.citationSteiner, T., Kaste, M., Katse, M., Forsting, M., Mendelow, D., Kwiecinski, H., Hacke, W. (2006). Recommendations for the management of intracranial haemorrhage - part I: Spontaneous intracerebral haemorrhage. The european stroke initiative writing committee and the writing committee for the EUSI executive committee. Cerebrovascular Diseases (Basel, Switzerland), 22(4), 294-316. doi:10.1159/000094831.
dc.identifier.citationSteiner, T., Rosand, J., & Diringer, M. (2006). Intracerebral hemorrhage associated with oral anticoagulant therapy: Current practices and unresolved questions. Stroke; A Journal of Cerebral Circulation, 37(1), 256-62. doi: 10.1161/01.STR.0000196989.09900.f8.
dc.identifier.citationTanaka, K. A., Szlam, F., Dickneite, G., & Levy, J. H. (2008). Effects of prothrombin complex concentrate and recombinant activated factor VII on vitamin K antagonist induced anticoagulation. Thrombosis Research, 122(1), 117-23. doi:10.1016/j.thromres.2007.09.002.
dc.identifier.citationVigué, B. (2009). Bench-To-Bedside review: Optimising emergency reversal of vitamin K antagonists in severe haemorrhage from theory to practice. Critical Care (London, England), 13(2), 209. doi:10.1186/cc7001.
dc.identifier.citationZubkov, A. Y., Mandrekar, J. N., Claassen, D. O., Manno, E. M., Wijdicks, E. F. M., & Rabinstein, A. A. (2008). Predictors of outcome in warfarinrelated intracerebral hemorrhage. Archives of Neurology, 65(10), 1320. doi: 10.1001/archinte.156.4.409.
dc.identifier.citationDowlatshahi, D., Demchuk, A.M., Flaherty, M.L., Ali, M., Lyden, P.L., Smith, E.E.,(2011). Defining hematoma expansión in intracerebral hemorrhage. Neurology, 76:1238 – 1244.
dc.identifier.citationKuwashiro, T., Yasaka, M., Itabashi, R., Nakagaki, H., Miyashita, F., Naritomi, H., Minematsu, K., (2011). Effect of Prothrombin Complex Concentrate on Hematoma Enlargement and Clinical Outcome in Patients with Anticoagulant – associated Intracerebral Hemorrhage. Cerebrovascular Disease, 31:170 – 176. Doi: 10.1159/000321766.
dc.identifier.citationCampbell, S.A., Altman, D.G., (1995). Estimating simple sizes for binary, ordered categorical, and continuous outcomes in two group comparisons. British Medical Journal, 311:1145 – 8.
dc.identifier.citationVan Swieten JC, Koudstaal PJ, Visser MC, et al. Interobserver agreement for the assessment of hándicap in stroke patients. Stroke. 1988; 19: 604 – 607.
dc.identifier.citationGoldhaber, S.Z., (2006). “Bridging” and mechanical heart valves: Perils, promises, and predictions. Circulation, 113: 470 – 472. Doi: 10.1161/ circulationaha.105.598268.
dc.identifier.citationStead, L., Jain, A., Bellolio, MF., Odufuye, AO., Dhillon, RK., Manivannan, V., Gilmore, RM., Rabinstein, AA., Chandra, R., Serrano, L., Yerragondu, N., Palamari, B., Decker, W. (2010). Effect of anticoagulant and antiplatelet therapy in patients with spontaneous intra-cerebral hemorrhage: Does medication use predict worse outcome?. Clinical Neurology and Neurosurgery, 112, 275 - 281. doi: 10.1016/j.clineuro.2009.12.002.
dc.identifier.citationBanerjee, A., Lip, G. (2011). Intracerebral Hemorrhage and Warfarin: Perceived Versus Actual Risk. Stroke, 42, 2383 - 84. doi:10.1161/ STROKEAHA.111.626739.
dc.identifier.citationDavis, S.M., Broderick, J., Hennerici, M., Brun, N.C., Diringer,; S.A. Mayer, ; K. Begtrup, ; and T. Steiner. (2006). Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhage. Neurology, 66, 1175 – 1181. 10.1212/01.wnl.0000256290.15120.37.
dc.identifier.urihttp://hdl.handle.net/10818/9368
dc.description86 Páginas.
dc.description.abstractEl ECV hemorrágico es una de las catástrofes más temidas con el uso de anticoagulantes orales, no solo por su mortalidad a corto plazo; estos tienden a crecer en las primeras horas aumentando significativamente su volumen, lo cual está estrechamente ligado al pronóstico neurológico. Por esa razón se plantea la necesidad de realizar un estudio clínico aleatorizado, para definir si el uso de PCC’s disminuye el tiempo de normalización del INR y la tasa de crecimiento del hematoma en pacientes con ECV hemorrágico asociado a anticoagulantes orales de tipo warfarina comparado con plasma fresco congelado y si a un año existe alguna diferencia en el estado neurológico de los pacientes de ambos grupos, medido a través de la escala mRankin.es_CO
dc.language.isospaes_CO
dc.publisherUniversidad de la Sabana
dc.sourceUniversidad de La Sabana
dc.sourceIntellectum Repositorio Universidad de La Sabana
dc.subjectHemorragia encefálica cerebral
dc.subjectHemorragia intracerebral
dc.subjectPlasma fresco congelado
dc.subjectProtrombina
dc.titleEfecto del manejo con concentrado de protrombina en comparación al plasma fresco congelado, en la hemorragia Intracerebral asociada a warfarina: Ensayo Clínico Aleatorizado; Estudio scorpioes_CO
dc.typebachelorThesis
dc.publisher.programEspecialización en Medicina Interna
dc.publisher.departmentFacultad de Medicina
dc.type.localTesis de especialización
dc.type.hasVersionpublishedVersion
dc.rights.accessRightsopenAccess
dc.creator.degreeEspecialista en Medicina Interna


Files in this item

Thumbnail
Name:
Carlos Hernando Salazar Triviño ...
Size:
1.033Mb
Format:
PDF
Description:
Ver documento en PDF
View/Open

This item appears in the following Collection(s)

Show simple item record